Estrogen-receptor Positive Invasive Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch Estrogen-receptor Positive Invasive Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib in Estrogen Receptor Positive Breast Cancer (NCT01594216) | Abramson Cancer Center at Penn Medicine | 2012-04-01 |
Track Estrogen-receptor Positive Invasive Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.